井寺制药(IDRA)

chuminhua2022-05-18 15:01

5月18日，Idera Pharmaceuticals 的股价上涨了 61%，此前该公司表示，一项合成 TLR-9 激动剂 tilsotolimod 治疗黑色素瘤的IIT试验在中期分析显示达到主要终点后提前停止。研究人员 Tanja de Gruijl 表示，II 期 INTRIM 1 研究的结果“表明在切除部位施用 tilsotolimod 可降低肿瘤阳性淋巴结的范围...查看全文

chuminhua2021-12-16 15:23

12月14日，Idera Pharmaceuticals 唯一的资产TLR9 激动剂 tilsotolimod 遇到了另一个障碍，因为艾伯维 (AbbVie) 将不再招募患者参与 Idera 的药物与其 在研单抗ABBV-368 的 1b 期头颈鳞癌的研究。
与此同时，该公司在周二收盘后表示，Idera 不再招募患者进入 tilsotolimod 与 BMS的 Yervoy 和 ...查看全文

晨曦大魔王2021-07-15 18:27

$井寺制药(IDRA)$ 天天阴跌查看全文

hazuki2021-06-23 22:46

$井寺制药(IDRA)$ 拉稀好！ 好拉稀！查看全文

TCLDBY2021-06-23 18:50

$井寺制药(IDRA)$ 今晚还能去到2吗查看全文

TCLDBY2021-06-23 00:20

$井寺制药(IDRA)$ 希望能回到2块查看全文

神鹰20072021-06-04 04:34

$井寺制药(IDRA)$ 🙏🏻🙏🏻查看全文

奥马哈买家俱乐部2021-05-12 23:14

$休斯敦能源(HUSA)$可以开始表演了$井寺制药(IDRA)$查看全文

神鹰20072021-04-27 01:30

$井寺制药(IDRA)$ still too cheap here ,will be 2+ soon at least查看全文

神鹰20072021-04-19 21:54

$井寺制药(IDRA)$ dip buy IMO 查看全文

美东时间 2011-08-11 21:30 Q2 2011 Idera Pharmaceuticals Inc Earnings Release

美东时间 2011-06-29 22:30 Idera Pharmaceuticals Inc at Biotechnology Industry Organization International Convention

$井寺制药(IDRA)$ 8-K - Current report Filed: 2019-01-09 AccNo: 0001104659-19-001373 Size: 56 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接

$井寺制药(IDRA)$ 8-K - Current report Filed: 2019-01-07 AccNo: 0001104659-19-000987 Size: 2 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接

$井寺制药(IDRA)$ 8-K - Current report Filed: 2018-12-18 AccNo: 0001104659-18-073565 Size: 27 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接

$井寺制药(IDRA)$ 内部交易: 2018-12-19,Director,SCHAFER CAROL ,买入,5000普通股, $3.33

$井寺制药(IDRA)$ 内部交易: 2018-12-19,Director,Goldberg Mark Alan ,买入,10000普通股, $3.19

$井寺制药(IDRA)$ 内部交易: 2018-12-20,Chief Medical Officer,Horobin Joanna ,买入,300普通股, $3.45

$井寺制药(IDRA)$ 8-K - Current report Filed: 2018-12-18 AccNo: 0001104659-18-073565 Size: 27 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接

$井寺制药(IDRA)$ 8-K - Current report Filed: 2018-12-14 AccNo: 0001104659-18-072949 Size: 2 MBItem 7.01: Regulation FD DisclosureItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接

$井寺制药(IDRA)$ 8-K - Current report Filed: 2018-11-26 AccNo: 0001104659-18-069928 Size: 320 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接

$井寺制药(IDRA)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2018-11-26 AccNo: 0001104659-18-069927 Size: 326 KB 网页链接